Saglam, Y. Et Al. 2017. Hybrid Arc Could Combine the Benefits of IMRT and VMAT to Deliver a Fast, Conformal, Homogeneous Treatment in Non-Small Cell Lung Cancer without Limitations of Low Dose Bath: A Planning Study. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27 , 161-170.

Saglam, Y., Bolukbası, Y., Alpan, V., Topkan, E., Kırsner, S., Ballo, M., ... Chang, J. Y.(2017). Hybrid Arc Could Combine the Benefits of IMRT and VMAT to Deliver a Fast, Conformal, Homogeneous Treatment in Non-Small Cell Lung Cancer without Limitations of Low Dose Bath: A Planning Study. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, 161-170.

Saglam, Yucel Et Al. "Hybrid Arc Could Combine the Benefits of IMRT and VMAT to Deliver a Fast, Conformal, Homogeneous Treatment in Non-Small Cell Lung Cancer without Limitations of Low Dose Bath: A Planning Study," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, 161-170, 2017

Saglam, Yucel Et Al. "Hybrid Arc Could Combine the Benefits of IMRT and VMAT to Deliver a Fast, Conformal, Homogeneous Treatment in Non-Small Cell Lung Cancer without Limitations of Low Dose Bath: A Planning Study." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, pp.161-170, 2017

Saglam, Y. Et Al. (2017) . "Hybrid Arc Could Combine the Benefits of IMRT and VMAT to Deliver a Fast, Conformal, Homogeneous Treatment in Non-Small Cell Lung Cancer without Limitations of Low Dose Bath: A Planning Study." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, pp.161-170.

@article{article, author={Yucel Saglam Et Al. }, title={Hybrid Arc Could Combine the Benefits of IMRT and VMAT to Deliver a Fast, Conformal, Homogeneous Treatment in Non-Small Cell Lung Cancer without Limitations of Low Dose Bath: A Planning Study}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2017, pages={161-170} }